We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+4.13%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$9.3B
AUM Growth
+$317M
Cap. Flow
+$101M
Cap. Flow %
1.08%
Top 10 Hldgs %
10.88%
Holding
383
New
29
Increased
184
Reduced
153
Closed
12

Top Buys

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$45.8M
2
VIAB
Viacom Inc. Class B
VIAB
+$43.5M
3
OC icon
Owens Corning
OC
+$41.4M
4
LIVN icon
LivaNova
LIVN
+$38.3M
5
NBL
Noble Energy, Inc.
NBL
+$38M

Top Sells

Rank Stock Value
1
RJF icon
Raymond James Financial
RJF
+$45.2M
2
PARA
Paramount Global Class B
PARA
+$38.9M
3
B
Barnes Group Inc.
B
+$36M
4
DVN icon
Devon Energy
DVN
+$32.7M
5
UMPQ
Umpqua Holdings Corp
UMPQ
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 18.89%
2 Industrials 15.21%
3 Healthcare 14.42%
4 Technology 12.15%
5 Consumer Discretionary 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISBC
351
DELISTED
Investors Bancorp, Inc.
ISBC
$1.25M 0.01%
97,762
-3,913
-4% -$52.7K
JBLU icon
352
JetBlue
JBLU
$1.65B
$1.22M 0.01%
64,371
– –
UMPQ
353
DELISTED
Umpqua Holdings Corp
UMPQ
$1.21M 0.01%
53,732
-1,225,647
-96% -$28.6M
RVNC
354
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.14M 0.01%
41,552
-2,926
-7% -$87.9K
MXL icon
355
MaxLinear
MXL
$5.88B
$1M 0.01%
64,322
-4,873
-7% -$98.4K
ACRS icon
356
Aclaris Therapeutics
ACRS
$830M
$986K 0.01%
49,392
+7,446
+18% +$138K
ABT icon
357
Abbott
ABT
$178B
$955K 0.01%
+15,652
New +$949K
ESPR
358
DELISTED
Esperion Therapeutics
ESPR
$930K 0.01%
23,737
+4,818
+25% +$243K
FANG icon
359
Diamondback Energy
FANG
$57.4B
$876K 0.01%
6,660
– –
SPY icon
360
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$807K 0.01%
2,975
-230
-7% -$62.1K
DK icon
361
Delek US
DK
$4.56B
$781K 0.01%
+15,563
New +$774K
UEIC icon
362
Universal Electronics
UEIC
$61.7M
$777K 0.01%
23,511
-1,781
-7% -$66.9K
STE icon
363
Steris
STE
$20.5B
$755K 0.01%
7,187
-6
-0.1% -$604
AMGN icon
364
Amgen
AMGN
$206B
$741K 0.01%
4,015
-698
-15% -$123K
BNY
365
Bank of New York Mellon
BNY
$107B
$583K 0.01%
10,810
-15
-0.1% -$828
BLUE
366
DELISTED
bluebird bio
BLUE
$471K 0.01%
232
-2,660
-92% -$6.06M
BMY icon
367
Bristol-Myers Squibb
BMY
$131B
$452K ﹤0.01%
8,169
+1,779
+28% +$96.1K
ZTS icon
368
Zoetis
ZTS
$30.4B
$430K ﹤0.01%
5,053
+6
+0.1% +$507
VLO icon
369
Valero Energy
VLO
$110B
$426K ﹤0.01%
3,842
+36
+0.9% +$4.04K
IWD icon
370
iShares Russell 1000 Value ETF
IWD
$83.4B
$259K ﹤0.01%
2,133
-1,732
-45% -$211K
LULU icon
371
lululemon athletica
LULU
$11.1B
$217K ﹤0.01%
+1,739
New +$185K
ACAD icon
372
Acadia Pharmaceuticals
ACAD
$4.74B
– –
-26,289
Closed -$591K
AMAT icon
373
Applied Materials
AMAT
$337B
– –
-365,097
Closed -$20.3M
AVA icon
374
Avista
AVA
$3.08B
– –
-239,301
Closed -$12.3M
BDX icon
375
Becton Dickinson
BDX
$48.4B
– –
-2,330
Closed -$493K
12 13 14
15
16

Similar funds

GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Rothschild & Co Asset Management US's Q2 2018 Portfolio in Review

As of Q2 2018, Rothschild & Co Asset Management US held 383 positions worth $9.3B, up 3.5% from $8.99B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Rothschild & Co Asset Management US's Q2 2018 filing shows 29 new, 184 increased, 153 reduced and 12 closed positions. Its largest new stake was Travelers Companies: 349,561 shares worth $42.8M. The largest sale was Raymond James Financial, an estimated $45.2M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Healthcare.

  • Rothschild & Co Asset Management US's largest Q2 2018 buy was Travelers Companies: 349,561 shares worth $42.8M.
  • Rothschild & Co Asset Management US added most to Owens Corning in Q2 2018, an estimated $41.4M increase.
  • Rothschild & Co Asset Management US's biggest Q2 2018 reduction was Raymond James Financial, cutting an estimated $45.2M.
  • Rothschild & Co Asset Management US fully exited Paramount Global Class B in Q2 2018, selling an estimated $38.9M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 11% of its $9.3B portfolio in Q2 2018.
  • Rothschild & Co Asset Management US opened 29 new positions and closed 12 in Q2 2018.
  • Rothschild & Co Asset Management US's portfolio value rose 3.5% quarter-over-quarter to $9.3B.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2018, filed 7 Aug 2018.